4 completed, 1 terminated, 1 unknown. 6 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 4, Terminated 1, Unknown 1 |
Follow ACC: new trials by email Literature Review of ACC trials Research Report on ACC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preventing OUD in Justice-Involved Youth Adolescent Community Reinforcement Approach, Assertive Continuing Care, Trauma Affect Regulation Guide for Education and Therapy - Substance Use Disorders, Recidivism | Not applicable | Unknown | Seattle Children's Hospital | 215 | 2021-01-20 | 2022-10-27 |
| Effect of the Nasal Gel "Nascum®-Plus" on Allergic Symptoms Nascum Plus, ACC - Rhinitis, Allergic, Seasonal | Not applicable | Completed | Fraunhofer-Institute of Toxicology and Experimental Medicine | 18 | 2018-12-12 | 2019-02-15 |
| Attention Training for Underserved Youth With Anxiety Attention Modification Program, Attention Control Condition - Anxiety | Not applicable | Completed | University of California, Los Angeles | 69 | 2017-09-01 | 2022-07-26 |
| A Single Arm Study Comparing ACC Supplement to CCS in Management of Hypoparathyroidism amorphous calcium carbonate - Hypoparathyroidism | Not applicable | Terminated | Amorphical Ltd. | 10 | 2013-04-01 | 2024-03-01 |
| Attention Training for Childhood Obsessive Compulsive Disorder Attention Modification Program, Attention Control Condition - Obsessive Compulsive Disorder | Not applicable | Completed | University of California, Los Angeles | 47 | 2013-04-01 | 2017-01-16 |
| Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity N Acetylcysteine - Hepatitis, Tuberculosis | Not applicable | Completed | National Research Institute of Tuberculosis and Lung Disease, Iran | 60 | 2007-11-01 | 2009-04-22 |
Anxiety Disorders (1) · Hepatitis (1) · Hypoparathyroidism (1) · Obsessive-Compulsive Disorder (1) · Opioid-Related Disorders (1) · Recidivism (1) · Rhinitis, Allergic, Seasonal (1) · Substance-Related Disorders (1) · Tuberculosis (1)
University of California, Los Angeles (2) · Amorphical Ltd. (1) · Fraunhofer-Institute of Toxicology and Experimental Medicine (1) · National Research Institute of Tuberculosis and Lung Disease, Iran (1) · Seattle Children's Hospital (1)
United States (3) · Germany (1) · Iran (1) · Israel (1)
Susanna Chang, PhD (2) · Denise Chavira, PhD (1) · Dity Natan, McS (1) · John Piacentini, PhD (1) · Kevin Haggerty, MSW PhD (1) · Kym Ahrens, MD MPH (1) · Philipp Badorrek, MD (1) · Shadi Baniasadi, PhD (1) · Sophia Ish-Shalom, MD (1)
PMID 37393415, PMID 39250243, PMID 39706330, PMID 41085955
R34MH095885 (1), UG3DA050189 (1)